Trial 1B-11-1

Breast Cancer Blood Biorepository.

Type: Specimen Study
Phase: Not Applicable
Status: Open to Accrual
Treatments:
Randomized: No
Defintions of terms and FAQ about clinical trials.

Trial Leaders/Researchers: Debasish Tripathy, M.D.
Other Trial Staff: Kristy Watkins, R.N., Nancy Perez, R.N., Jessica Levano, R.N., Yanli Wang, D.M.

Staff may log in to see study documents.

You may participate in this study if:

	Requirement
1	Individuals of all racial and ethnic groups who are 18 years or older
2	Cohort 1: Women with a high-risk of breast cancer but no evidence of disease, including: (a) Women with BRCA1 or BRCA2 germline mutations; (b) Women with a family members with breast and/or ovarian cancer; (c) Women of Ashkenazi Jewish descent; (d) Women with a diagnosis of ovarian cancer; (e) Women with high mammographic breast density (BIRAD score 4-5); (f) Women with a history of atypical ductal hyperplasia Cohort 2: Women with stage I-III invasive ductal or lobular breast cancer, to be enrolled prior to definitive surgery for breast cancer Cohort 3: Women with stage IV invasive ductal or lobular breast cancer, to be enrolled at any time Cohort 4: Women with ductal or lobular carcinoma in situ, to be enrolled at the time of diagnosis and before definitive surgery Cohort 5: Normal controls, includes healthy family members of patients, patients with benign breast disorders, patients from families carrying a known genetic mutation who themselves are found not to carry the mutation.
3	Signed an approved study-specific informed consent and HIPAA

You may not participate in this study if:

1	Hgb <8.0
2	Pregnancy (except for Cohort 5)

For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3111.